Document is current
Any future updates will be listed below
-
Authors
Doglioni, Ginevra https://orcid.org/0000-0002-9470-4476
Fernández-García, Juan https://orcid.org/0000-0003-3422-3627
Igelmann, Sebastian https://orcid.org/0000-0001-6133-4184
Altea-Manzano, Patricia https://orcid.org/0000-0002-7075-2051
Blomme, Arnaud https://orcid.org/0000-0003-4183-8726
La Rovere, Rita
Liu, Xiao-Zheng https://orcid.org/0000-0002-8452-6848
Liu, Yawen
Tricot, Tine https://orcid.org/0000-0002-6710-4838
Nobis, Max https://orcid.org/0000-0002-1861-1390
An, Ning https://orcid.org/0000-0001-9512-6869
Leclercq, Marine https://orcid.org/0000-0002-3974-0060
El Kharraz, Sarah
Karras, Panagiotis https://orcid.org/0000-0002-7642-0875
Hsieh, Yu-Heng
Solari, Fiorella A.
Martins Nascentes Melo, Luiza https://orcid.org/0000-0002-5980-5220
Allies, Gabrielle
Scopelliti, Annalisa
Rossi, Matteo https://orcid.org/0000-0002-1206-1244
Vermeire, Ines https://orcid.org/0000-0003-3366-7410
Broekaert, Dorien https://orcid.org/0000-0002-9777-1607
Ferreira Campos, Ana Margarida https://orcid.org/0000-0002-8832-7686
Neven, Patrick
Maetens, Marion
Van Baelen, Karen
Alkan, H. Furkan https://orcid.org/0000-0003-0078-248X
Planque, Mélanie
Floris, Giuseppe
Sickmann, Albert
Tasdogan, Alpaslan https://orcid.org/0000-0003-2543-852X
Marine, Jean-Christophe https://orcid.org/0000-0003-2433-9837
Scheele, Colinda L. G. J. https://orcid.org/0000-0001-8999-5451
Desmedt, Christine https://orcid.org/0000-0002-5223-5579
Bultynck, Geert https://orcid.org/0000-0002-5968-4828
Close, Pierre
Fendt, Sarah-Maria https://orcid.org/0000-0001-6018-9296
- License Information
-
More Information
Article History
Received: 30 June 2023
Accepted: 1 November 2024
First Online: 1 January 2025
Competing interests
: S.-M.F. has received funding from BlackBelt Therapeutics, Auron Therapeutics, Gilead and Alesta Therapeutics, is on the advisory board of Alesta Therapeutics and has consulted for Fund+ and Droia Ventures. The other authors declare no competing interests.
